Stockreport

IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF WILMINGTON, Del., April 16, 2024 BUSINESS WIRE )--Updated exploratory results from the TOPAZ-1 Phase III trial showed AstraZeneca's IMFINZI ® (durvalumab) in combinatio [Read more]